Patent Assignment
Reel/Frame 069348/0037
Assignment of Assignor's Interest
Recorded: 2024-11-20
Pages: 4
Assignor
TAKEDA PHARMACEUTICALS U.S.A., INC.
Executed: 2017-04-20
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Property
(1)
Method of Treating Crohn’S Disease by Administering a Triple Combination Therapy of Anti-Integrin Antibody, Adalimumab and Methotrexate
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 20, 2024
From: COLOMBEL, JEAN-FREDERIC
To: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Reel/Frame 069347/0983 →
Assignment of Assignor's Interest
Nov 20, 2024
From: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 069348/0085 →
Assignment of Assignor's Interest
Nov 20, 2024
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 069348/0146 →
Assignment of Assignor's Interest
Nov 20, 2024
From: MILLENNIUM PHARMACEUTICALS, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 069406/0718 →
Assignment of Assignor's Interest
Nov 20, 2024
From: LISSOOS, TREVOR WARREN
To: TAKEDA PHARMACEUTICALS U.S.A., INC.
Reel/Frame 069406/0863 →